| mishravikashkumar650@gmail.com |
| Business Type | Exporter, Supplier, Trader |
| Dosage | 80mg |
| Indications | Non-small Cell Lung Cancer (NSCLC) |
| Application | Treatment Of Specific Types Of NSCLC |
| Click to view more | |
Product Details
Osimertinib is an oral, third-generation targeted therapy used to treat specific types of non-small cell lung cancer (NSCLC) with EGFR mutations. It is prescribed for early-stage tumor removal, locally advanced unresectable disease,
Raise your Query
Hi! Simply click below and type your query.
Our experts will reply you very soon.